Beyond Safety: Strategic In Vitro Testing for Targeted Cosmetic Efficacy Claims
The global cosmetics industry is undergoing a profound transformation, driven by increasingly sophisticated regulatory frameworks and consumers who demand scientifically proven efficacy. For R&D teams, the core challenge in cosmetics testing is no longer solely about confirming a product is safe—it is about strategically designing a program that provides mechanistic evidence for specific claims and accelerates time-to-market. This requires a mechanism-driven, tiered approach integrating advanced in vitro methodologies. Implementing comprehensive cosmetics testing strategies early in the R&D pipeline has become the decisive factor in developing market-leading products. The fundamental driver is the evolution of regulatory standards worldwide. Regulatory frameworks in key markets, including China’s NMPA efficacy-claim requirements and the EU’s common criteria for cosmetic claims, increasingly require
Read More